Quibim to present three of its latest advances in oncology research at ASCO 2024 conference
These studies explore the use of advanced radiomics techniques and artificial intelligence-based analysis for the prediction of responses to oncology therapies and mutational status in lung cancer.
Under the claim “The art and science of cancer care: from comfort to cure,” the ASCO 2024 conference will be held in Chicago at the McCormick Center from May 31 to June 4.
Quibim, in its strong commitment to further transform medical care through innovative imaging solutions, will present three submitted and approved abstracts of its groundbreaking advances in medical imaging applied to oncology.
These studies explore the use of advanced radiomics techniques and artificial intelligence-based analysis for the prediction of responses to oncology therapies and mutational status in lung cancer.